1.
Left Ventricular Mass in Patients With a Cardiomyopathy After Treatment With Anthracyclines
by Neilan, Tomas G., MD
The American journal of cardiology, 2012, Vol.110 (11), p.1679-1686
2.
Myocardial Extracellular Volume by Cardiac Magnetic Resonance Imaging in Patients Treated With Anthracycline-Based Chemotherapy
by Neilan, Tomas G., MD
The American journal of cardiology, 2013, Vol.111 (5), p.717-722
3.
Short-Term Effects of Extended-Release Niacin With and Without the Addition of Laropiprant on Endothelial Function in Individuals With Low HDL-C: A Randomized, Controlled Crossover...
by Nasser Figueiredo, Valeria, PhD
Clinical therapeutics, 2014, Vol.36 (6), p.961-966
4.
Diabetes mellitus unawareness is a strong determinant of mortality in patients manifesting myocardial infarction
by Figueiredo, Valéria N
Current medical research and opinion, 2013, Vol.29 (11), p.1423-1427
5.
Additional reduction in blood pressure after cholesterol-lowering treatment by statins ( lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting en...
by Spósito, Andrei C
The American journal of cardiology, 1999, Vol.83 (10), p.1497-1499
6.
Myocardial Extracellular Volume by Cardiac Magnetic Resonance in Patients treated with Anthracycline-based Chemotherapy
by Neilan, Tomas G Tomas G
The American journal of cardiology, 2012, Vol.111 (5), p.717-722
7.
Cholesterol lowering with statins reduces exercise-induced myocardial ischemia in hypercholesterolemic patients with coronary artery disease
by Ramires, Jose Antonio F
The American journal of cardiology, 2001, Vol.88 (10), p.1134-1138
8.
A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial
by Vinereanu, Dragos
The Lancet (British edition), 2017, Vol.390 (10104), p.1737-1746
9.
Simvastatin Prevents Load-Induced Protein Tyrosine Nitration in Overloaded Hearts
by Nadruz, Wilson
Hypertension (Dallas, Tex. 1979), 2004, Vol.43 (5), p.1060-1066
10.
Long-term antianginal and antiischemic effects of mibefradil, the novel T-type calcium channel blocker: A multicenter, double-blind, placebo-controlled, randomized comparison with...
by Davies, Graham J
The American heart journal, 1997, Vol.134 (2), p.220-228
